Carvedilol Drug Market Analysis

The market is segmented by application into high blood pressure, congestive heart failure (CHF), ventricular dysfunction, and others, out of which, the congestive heart failure (CHF) segment is anticipated to hold a substantial share in the global carvedilol drug market over the forecast period on account of increasing prevalence of CHF. CHF is caused when muscles in the heart are unable to pump, mostly due to fluid build-up in the heart. High levels of cholesterol is the most prominent contributing factor for congestive heart failure.

Our in-depth analysis of the global market includes the following segments: